Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds
Manuscript Number:
22-0158R1
Author(s):
Alicia Algeciras-Schimnich, Bradley F. Boeve, Jonathan Graff-Radford, Clifford R. Jack Jr., Kejal Kantarci, David S. Knopman, Timothy G. Lesnick, Val J. Lowe, Stuart J. McCarter, Michelle M. Mielke, Ronald C. Petersen, Scott A. Przybelski, Alejandro Rabinstein, Vijay K. Ramanan, Prashanthi Vemuri
Disclosures
Alicia Algeciras-Schimnich
Nothing to Disclose
Bradley F. Boeve
Consulting Fees:
Tau Consortium
Patents/Royalties
Dr. Boeve received royalties from the book entitled Behavioral Neurology Of Dementia (Cambridge Medicine, 2009, 2017)
Grants
Agency:
NIH
Agency:
Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program
Agency:
Little Family Foundation
Jonathan Graff-Radford
Grants
Agency:
NIH
Clifford R. Jack Jr.
Consulting Fees:
Biogen
Grants
Agency:
NIH
Agency:
Alexander Family Alzheimer’s Disease Research Professorship of the Mayo Clinic
Kejal Kantarci
Consulting Fees:
Biogen
Grants
Agency:
Avid Radiopharmaceuticals
Agency:
Eli Lilly
Agency:
NIH
Agency:
Alzheimer’s Drug Discovery Foundation
Agency:
Foundation Dr. Corinne Schulerand
Agency:
Katherine B. Andersen Foundation
David S. Knopman
Grants
Agency:
NIH
Timothy G. Lesnick
Nothing to Disclose
Val J. Lowe
Consulting Fees:
Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research
Grants
Agency:
NIH
Agency:
GE Healthcare
Agency:
Siemens Molecular Imaging
Agency:
AVID Radiopharmaceuticals
Stuart J. McCarter
Nothing to Disclose
Michelle M. Mielke
Consulting Fees:
Biogen, Brain Protection Company, and LabCorp
Grants
Agency:
NIH
Agency:
DOD
Ronald C. Petersen
Consulting Fees:
Roche, Inc.; Merck, Inc.; Biogen, Inc
Patents/Royalties
He receives royalties from Oxford University Press and UpToDate